Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risks of Ramadan Fasting in Patients With Primary Adrenal Insufficiency Treated With Prednisolone.

NCT07367425 is registered in ClinicalTrials.gov with Hopital La Rabta as lead sponsor.

NCT NCT07367425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07367425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risks of Ramadan Fasting in Patients With Primary Adrenal Insufficiency Treated With Prednisolone.
Lead sponsor
Hopital La Rabta
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 22, 2026
Completion date
March 30, 2026
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

continuous glucose monitoring, dehydration, hypoglycemia non-diabetic, prednisolone, primary adrenal insufficiency, ramadan fasting